Drug × Cancer matrix

Drugs that target a gene either directly (oncogene) or via a synthetic-lethal partner (SLP) of a mutated tumour suppressor (TSG). Cell colour shows the strongest known status of that drug for that cancer subtype: approved clinical trial repositionable (potential reuse, no evidence yet) or blank.

Cancer key
GBM — Glioblastoma (CNS astrocytoma grade IV) LUAD — Lung adenocarcinoma SCLC — Small cell lung carcinoma LUSC — Lung squamous cell carcinoma OAC — Oesophageal adenocarcinoma OSCC — Oesophageal squamous cell carcinoma PDAC — Pancreatic ductal adenocarcinoma
Relationship
Show
Clear
Showing 200 of 386 drug-target rows in SSL view, for TSG = CDK12.
Drug TSG SLP (drug target) GBM LUAD SCLC LUSC OAC OSCC PDAC #
neo212 oral capsule, ipilimumab, pembrolizumab, nivolumab, regorafenib, carboplatin, paclitaxel, folfiri protocol, bevacizumab CDK12 NTRK1 4
regorafenib, (stivarga, bay73-4506), nivolumab (opdivo) CDK12 NTRK1 4
trastuzumab emtansine CDK12 ERBB2 7
tucatinib CDK12 ERBB2 7
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib CDK12 ERBB2 3
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib CDK12 NTRK1 3
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib CDK12 WEE1 3
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib CDK12 CSK 3
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib CDK12 LCK 3
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib CDK12 PIK3CD 3
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib CDK12 AKT2 3
afatinib CDK12 ERBB2 3
futibatinib, pembrolizumab, cisplatin, 5-fu, oxaliplatin, leucovorin, levoleucovorin, irinotecan CDK12 TOP1 3
lurbinectedin, irinotecan CDK12 TOP1 3
mrtx849, pembrolizumab, cetuximab, afatinib CDK12 ERBB2 3
lapatinib CDK12 ERBB2 7
sacituzumab govitecan CDK12 TOP1 7
topotecan CDK12 TOP1 7
trastuzumab deruxtecan CDK12 TOP1 5
adavosertib, radiation therapy CDK12 WEE1 2
alectinib, brigatinib, lorlatinib 100 mg, osimertinib, sotorasib, dabrafenib, trametinib, selpercatinib, pembrolizumab, cemiplimab, nivolumab, carboplatin, pemetrexed, paclitaxel CDK12 ERBB2 2
alectinib, brigatinib, lorlatinib 100 mg, osimertinib, sotorasib, dabrafenib, trametinib, selpercatinib, pembrolizumab, cemiplimab, nivolumab, carboplatin, pemetrexed, paclitaxel CDK12 IGF1R 2
alendronate, etidronate, ibandronate, risedronate, raloxifene CDK12 FDPS 2
alvocidib, paclitaxel CDK12 CDK8 2
alvocidib, paclitaxel CDK12 CDK9 2
alvocidib, paclitaxel CDK12 CDK5 2
apatinib, irinotecan CDK12 TOP1 2
asp2138, pembrolizumab, oxaliplatin, leucovorin, fluorouracil, ramucirumab, paclitaxel, irinotecan CDK12 TOP1 2
asp3082, cetuximab, leucovorin, oxaplatin, fluorouracil, irinotecan, nanoparticle albumin-bound-paclitaxel, gemcitabine CDK12 TOP1 2
bevacizumab, dasatinib, fluorouracil, leucovorin, leucovorin calcium, oxaliplatin, quality-of-life assessment CDK12 CSK 2
bevacizumab, dasatinib, fluorouracil, leucovorin, leucovorin calcium, oxaliplatin, quality-of-life assessment CDK12 LCK 2
bryostatin 1, paclitaxel CDK12 PRKCA 2
cetuximab, cisplatin, irinotecan, radiation therapy, surgery CDK12 TOP1 2
cixutumumab, everolimus, laboratory biomarker analysis, octreotide acetate, pharmacological study CDK12 IGF1R 2
cixutumumab, laboratory biomarker analysis, paclitaxel, pharmacological study CDK12 IGF1R 2
eft226, sotorasib, fulvestrant, abemaciclib, trastuzumab CDK12 ERBB2 2
entrectinib, entrectinib, alectinib, atezolizumab, ipatasertib, trastuzumab emtansine, idasanutlin, inavolisib, belvarafenib, pralsetinib, gdc-6036, camonsertib CDK12 ERBB2 2
entrectinib, entrectinib, alectinib, atezolizumab, ipatasertib, trastuzumab emtansine, idasanutlin, inavolisib, belvarafenib, pralsetinib, gdc-6036, camonsertib CDK12 NTRK1 2
inbrx-109, carboplatin, cisplatin, pemetrexed, 5-fluorouracil, irinotecan, temozolomide CDK12 TOP1 2
irinotecan, capecitabine CDK12 TOP1 2
irinotecan, docetaxel CDK12 TOP1 2
ly4066434., cetuximab, nab paclitaxel, gemcitabine, oxaliplatin, leucovorin, irinotecan, 5fluorouracil, carboplatin, cisplatin, pemetrexed, pembrolizumab CDK12 TOP1 2
nintedanib CDK12 LCK 2
nintedanib, pembrolizumab CDK12 LCK 2
olaparib CDK12 PARP3 2
pembrolizumab, paclitaxel, docetaxel, irinotecan CDK12 TOP1 2
radiotherapy targeted to the primary lesion, radiotherapy targeted to the metastatic lesions, anti-pd-1 monoclonal antibody, trastuzumab, chemotherapy, r0 total/subtotal gastrectomy with d2 lymphadenectomy, metastasectomy, local ablative therapies CDK12 ERBB2 2
regorafenib CDK12 NTRK1 2
regorafenib, laboratory biomarker analysis CDK12 NTRK1 2
rubitecan CDK12 TOP1 2
trastuzumab CDK12 ERBB2 2
trastuzumab, abt-806, bemarituzumab, ramucirumab, nivolumab, standard cytotherapy CDK12 ERBB2 2
trastuzumab, tipifarnib CDK12 ERBB2 2
entrectinib CDK12 NTRK1 7
rosuvastatin CDK12 HMGCR 7
18f-fluoromisonidazole, cediranib maleate, laboratory biomarker analysis, olaparib, positron emission tomography CDK12 PARP3 1
2b3-101, trastuzumab, 2b3-101 60 mg/m2 every 4 weeks, 2b3-101 50 mg/m2 every 3 weeks CDK12 ERBB2 1
5 fluorouracil, leucovorin, irinotecan, oxaliplatin CDK12 TOP1 1
5-fu, leucovorin, docetaxel, oxaliplatin (flot), trastuzumab, post-operative treatment trastuzumab mono therapy CDK12 ERBB2 1
9-ing-41, gemcitabine - 21 day cycle, doxorubicin., lomustine, carboplatin., nab paclitaxel., paclitaxel., gemcitabine - 28 day cycle, irinotecan CDK12 TOP1 1
abemaciclib, irinotecan, temozolomide, dinutuximab, gm-csf CDK12 TOP1 1
adavosertib CDK12 WEE1 1
adavosertib, laboratory biomarker analysis, pharmacological study, radiation therapy CDK12 WEE1 1
adavosertib, radiation therapy, temozolomide CDK12 WEE1 1
adjuvant therapy, temozolomide, valproic acid, radiation therapy CDK12 CDKN1A 1
adriamycin, cyclophosphamide, vindesine, valproic acid CDK12 CDKN1A 1
afatinib, biopsy, biospecimen collection, computed tomography, echocardiography, magnetic resonance imaging, radionuclide imaging CDK12 ERBB2 1
afatinib, dasatinib, palbociclib, everolimus, olaparib CDK12 PARP3 1
afatinib, dasatinib, palbociclib, everolimus, olaparib CDK12 ERBB2 1
afatinib, dasatinib, palbociclib, everolimus, olaparib CDK12 CSK 1
afatinib, dasatinib, palbociclib, everolimus, olaparib CDK12 LCK 1
afatinib, docetaxel, radiation therapy CDK12 ERBB2 1
afatinib, gefitinib CDK12 ERBB2 1
afatinib, irinotecan CDK12 ERBB2 1
afatinib, irinotecan CDK12 TOP1 1
aldesleukin, therapeutic autologous lymphocytes, zoledronic acid CDK12 FDPS 1
aldoxorubicin, topotecan CDK12 TOP1 1
alvocidib, docetaxel CDK12 CDK8 1
alvocidib, docetaxel CDK12 CDK9 1
alvocidib, docetaxel CDK12 CDK5 1
alvocidib, gemcitabine hydrochloride, 3-dimensional conformal radiation therapy, laboratory biomarker analysis CDK12 CDK8 1
alvocidib, gemcitabine hydrochloride, 3-dimensional conformal radiation therapy, laboratory biomarker analysis CDK12 CDK9 1
alvocidib, gemcitabine hydrochloride, 3-dimensional conformal radiation therapy, laboratory biomarker analysis CDK12 CDK5 1
aminolevulinic acid CDK12 ALAD 1
aminolevulinic acid, surgical resection CDK12 ALAD 1
amrubicin, topotecan CDK12 TOP1 1
andecaliximab, gemcitabine, nab-paclitaxel, carboplatin, pemetrexed, leucovorin, oxaliplatin, 5-fu, bevacizumab, irinotecan, paclitaxel CDK12 TOP1 1
arsenic trioxide CDK12 CDKN1A 1
arsenic trioxide, radiation therapy CDK12 CDKN1A 1
arsenic trioxide, temozolomide, adjuvant therapy, intensity-modulated radiation therapy, radiation therapy CDK12 CDKN1A 1
at-101, topotecan CDK12 TOP1 1
atorvastatin, temozolomide, radiotherapy CDK12 HMGCR 1
avastin, temozolomide, irinotecan CDK12 TOP1 1
avastin, temozolomide, radiation therapy (xrt), irinotecan CDK12 TOP1 1
avelumab, irinotecan, paclitaxel, best supportive care (bsc) CDK12 TOP1 1
azd0901, 5-fluorouracil, leucovorin, l-leucovorin, irinotecan, nanoliposomal irinotecan, gemcitabine CDK12 TOP1 1
azd1775, olaparib CDK12 PARP3 1
azenosertib, biopsy, biospecimen collection, computed tomography, echocardiography, magnetic resonance imaging, multigated acquisition scan, trastuzumab deruxtecan CDK12 TOP1 1
bbi608, nab-paclitaxel, gemcitabine, oxaliplatin, leucovorin, irinotecan, fluorouracil, mm-398 CDK12 TOP1 1
bemarituzumab, paclitaxel, ramucirumab, bemarituzumab, irinotecan, bemarituzumab, trifluridine/tipiracil CDK12 TOP1 1
berzosertib, computed tomography assisted biopsy, endoscopic biopsy, irinotecan, magnetic resonance imaging CDK12 TOP1 1
berzosertib, sacituzumab govitecan CDK12 TOP1 1
bevacizumab [avastin], irinotecan, temozolomide CDK12 TOP1 1
bevacizumab, cediranib, cediranib maleate, olaparib CDK12 PARP3 1
bevacizumab, dasatinib, placebo CDK12 CSK 1
bevacizumab, dasatinib, placebo CDK12 LCK 1
bevacizumab, irinotecan CDK12 TOP1 1
bevacizumab, irinotecan, dynamic contrast-enhanced magnetic resonance imaging CDK12 TOP1 1
bevacizumab, temozolomide, radiation therapy (xrt), topotecan CDK12 TOP1 1
bi 764532, topotecan, single agent chemotherapy CDK12 TOP1 1
biopsy, biospecimen collection, ceralasertib, computed tomography, echocardiography, multigated acquisition scan, positron emission tomography, trastuzumab deruxtecan CDK12 TOP1 1
biopsy, biospecimen collection, computed tomography, copanlisib, magnetic resonance imaging CDK12 PIK3CD 1
biopsy, biospecimen collection, computed tomography, endoscopic ultrasound, fluorouracil, irinotecan, leucovorin, lymph node biopsy, magnetic resonance imaging, oxaliplatin, pembrolizumab, photodynamic therapy, positron emission tomography, questionnaire administration, verteporfin CDK12 TOP1 1
biopsy, biospecimen collection, computed tomography, larotrectinib, magnetic resonance imaging CDK12 NTRK1 1
biopsy, biospecimen collection, computed tomography, magnetic resonance imaging, olaparib CDK12 PARP3 1
biopsy, biospecimen collection, computed tomography, magnetic resonance imaging, olaparib, pembrolizumab CDK12 PARP3 1
biopsy, biospecimen collection, copanlisib, radiologic examination CDK12 PIK3CD 1
biopsy, biospecimen collection, echocardiography, pertuzumab, radiologic examination, trastuzumab CDK12 ERBB2 1
biospecimen collection, computed tomography, core biopsy, fluorouracil, irinotecan, leucovorin, leucovorin calcium, oxaliplatin, quemliclustat, zimberelimab CDK12 TOP1 1
biospecimen collection, computed tomography, magnetic resonance imaging, olaparib, placebo administration CDK12 PARP3 1
bl-b01d1, irinotecan, paclitaxel, docetaxel CDK12 TOP1 1
bl-b01d1, topotecan CDK12 TOP1 1
bnt327 dose level 1 (dl1), bnt327 dose level 2 (dl2), etoposide, carboplatin, paclitaxel, topotecan CDK12 TOP1 1
bortezomib, irinotecan CDK12 TOP1 1
byl719, poziotinib, nintedanib, abemaciclib, durvalumab,tremelimumab CDK12 LCK 1
camrelizumab, docetaxel, irinotecan CDK12 TOP1 1
camrelizumab, irinotecan, paclitaxel, paclitaxel-albumin, docetaxel, anlotinib CDK12 TOP1 1
capecitabine, fluorouracil, laboratory biomarker analysis, pharmacological study, stereotactic body radiation therapy, zoledronic acid CDK12 FDPS 1
capecitabine, medi4736 (durvalumab), trastuzumab, rucaparib, ramucirumab CDK12 PARP3 1
capecitabine, medi4736 (durvalumab), trastuzumab, rucaparib, ramucirumab CDK12 ERBB2 1
capecitabine, oxaliplatin, irinotecan CDK12 TOP1 1
capivasertib CDK12 AKT2 1
carboplatin, irinotecan CDK12 TOP1 1
carboplatin, laboratory biomarker analysis, paclitaxel, quality-of-life assessment, radiation therapy, therapeutic conventional surgery, trastuzumab CDK12 ERBB2 1
carboxylesterase-expressing allogeneic neural stem cells, irinotecan, irinotecan hydrochloride, laboratory biomarker analysis, pharmacological study CDK12 TOP1 1
ceralasertib, olaparib, durvalumab CDK12 PARP3 1
cetuximab, bevacizumab, irinotecan CDK12 TOP1 1
cetuximab, irinotecan, oxaliplatin, uft CDK12 TOP1 1
cetuximab, trastuzumab CDK12 ERBB2 1
cisplatin, 5-fluorouracil or capecitabine, trastuzumab, pertuzumab, gastrectomy CDK12 ERBB2 1
cisplatin, fluorouracil, gemcitabine, irinotecan, leucovorin, nab-paclitaxel, oxaliplatin, radiation therapy CDK12 TOP1 1
cisplatin, gleevec™, irinotecan CDK12 TOP1 1
cisplatin, irinotecan, capecitabine CDK12 TOP1 1
cobimetinib, olaparib, onvansertib, azenosertib, saruparib, tremelimumab CDK12 PARP3 1
cytoreductive surgery, perifosine, temsirolimus CDK12 PRKCA 1
dasatinib, erlotinib hydrochloride, gemcitabine hydrochloride CDK12 CSK 1
dasatinib, erlotinib hydrochloride, gemcitabine hydrochloride CDK12 LCK 1
dasatinib, gemcitabine hydrochloride, laboratory biomarker analysis, mutation analysis, nucleic acid sequencing, immunohistochemistry staining method CDK12 CSK 1
dasatinib, gemcitabine hydrochloride, laboratory biomarker analysis, mutation analysis, nucleic acid sequencing, immunohistochemistry staining method CDK12 LCK 1
dasatinib, laboratory biomarker analysis, physiologic testing CDK12 CSK 1
dasatinib, laboratory biomarker analysis, physiologic testing CDK12 LCK 1
dasatinib, mfolfox6 CDK12 CSK 1
dasatinib, mfolfox6 CDK12 LCK 1
dasatinib, pharmacological study CDK12 CSK 1
dasatinib, pharmacological study CDK12 LCK 1
dasatinib, temozolomide, placebo, radiation therapy CDK12 CSK 1
dasatinib, temozolomide, placebo, radiation therapy CDK12 LCK 1
db-1310, trastuzumab, osimertinib CDK12 ERBB2 1
digoxin, 5fluorouracil, calcium leucovorin, irinotecan, oxaliplatin CDK12 TOP1 1
disitamab vedotin, tucatinib CDK12 ERBB2 1
docetaxel, leucovorin, fluorouracil, cisplatin, docetaxel, cisplatin, fluorouracil, neulasta, or neupogen, docetaxel, leukvorin, flurouracil, cisplatin, trastuzumab CDK12 ERBB2 1
docetaxel, oxaliplatin, capecitabine, trastuzumab CDK12 ERBB2 1
doxorubicin, cisplatin, 5-fluorouracil CDK12 TOP1 1
durvalumab, olaparib CDK12 PARP3 1
durvalumab, olaparib, cediranib CDK12 PARP3 1
durvalumab, oxaliplatin, irinotecan, calcium folinate (leucovorin), fluorouracil, pegylated g-csf CDK12 TOP1 1
edotecarin, temozolomide, carmustine (bcnu), lomustine (ccnu) CDK12 TOP1 1
ep0057, olaparib CDK12 PARP3 1
evorpacept (alx148), trastuzumab, ramucirumab, paclitaxel CDK12 ERBB2 1
fluorouracil (5-fu), capecitabine, durvalumab, oxaliplatin, trastuzumab, trastuzumab deruxtecan, cisplatin, pembrolizumab, volrustomig, rilvegostomig CDK12 ERBB2 1
fluorouracil (5-fu), capecitabine, durvalumab, oxaliplatin, trastuzumab, trastuzumab deruxtecan, cisplatin, pembrolizumab, volrustomig, rilvegostomig CDK12 TOP1 1
fluorouracil, irinotecan sucrosofate, laboratory biomarker analysis, leucovorin calcium, rucaparib CDK12 PARP3 1
fluorouracil, irinotecan, irinotecan hydrochloride, leucovorin, leucovorin calcium, nivolumab, oxaliplatin, therapeutic conventional surgery CDK12 TOP1 1
fluorouracil, leucovorin calcium, oxaliplatin, irinotecan, nivolumab, magnetic resonance imaging, computed tomography, biospecimen collection, questionnaire administration CDK12 TOP1 1
fluorouracil, oxaliplatin, irinotecan CDK12 TOP1 1
gemcitabine, nab-paclitaxel, irinotecan, intensity-modulated radiation therapy (imrt) CDK12 TOP1 1
gemcitabine, oxaliplatin, imatinib CDK12 NTRK1 1
gemcitabine, taxotere, xeloda, cisplatin, irinotecan CDK12 TOP1 1
ifinatamab deruxtecan, docetaxel, paclitaxel, irinotecan CDK12 TOP1 1
imab362, zoledronic acid, interleukin-2 (1 million iu), interleukin-2 (3 million iu) CDK12 FDPS 1
imatinib, irinotecan, carboplatin CDK12 NTRK1 1
imatinib, irinotecan, carboplatin CDK12 TOP1 1
insulin degludec, insulin glargine CDK12 IGF1R 1
irinotecan hydrochloride liposome injection, topotecan CDK12 TOP1 1
irinotecan, 5-fluorouracil, leucovorin CDK12 TOP1 1
irinotecan, bevacizumab, fdopa-pet/mri imaging CDK12 TOP1 1
irinotecan, carboplatin, bevacizumab CDK12 TOP1 1
irinotecan, carboplatin, bevacizumab, radiation CDK12 TOP1 1
irinotecan, carboplatin, bevacizumab, radiation therapy CDK12 TOP1 1
irinotecan, cisplatin, simvastatin CDK12 TOP1 1
irinotecan, cisplatin, simvastatin CDK12 HMGCR 1
irinotecan, ibi343, paclitaxel CDK12 TOP1 1
irinotecan, leucovorin, 5-fluorouracil, docetaxel, cisplatin, leucovorin, 5-fluorouracil CDK12 TOP1 1
irinotecan, lurbinectedin, irinotecan, topotecan, lurbinectedin CDK12 TOP1 1
irinotecan, radiation therapy CDK12 TOP1 1
irinotecan, ramucirumab, blood for angiome profiling, blood for cfdna CDK12 TOP1 1
kc1036, irinotecan, docetaxel, s-1 CDK12 TOP1 1
laboratory biomarker analysis, lapatinib, lapatinib ditosylate, pharmacological study, therapeutic conventional surgery CDK12 ERBB2 1
laboratory biomarker analysis, linsitinib, pharmacological study, topotecan hydrochloride CDK12 IGF1R 1
laboratory biomarker analysis, perifosine, temsirolimus, therapeutic conventional surgery CDK12 PRKCA 1
Approval data manually curated from National Cancer Institute and Drugs@FDA. Clinical trials from ClinicalTrials.gov. Repositionable candidates from cansar.ai — these are potential drug-cancer reuse candidates, not evidence of efficacy.